Bidirectional Associations of Depressive Symptoms and Cognitive Function Over Time.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
    • Publication Information:
      Original Publication: Chicago, IL : American Medical Association, [2018]-
    • Subject Terms:
      Depression*/epidemiology ; Cognitive Dysfunction*/epidemiology ; Cognitive Dysfunction*/psychology ; Cognition*/physiology; Humans ; Female ; Male ; Middle Aged ; Aged ; Cohort Studies ; Cross-Sectional Studies ; England/epidemiology
    • Abstract:
      Importance: Cognitive decline and depressive symptoms often co-occur among older adults, and they share several mechanisms. Despite the fact that cognitive dysfunction has been linked to increased depressive symptoms, the directionality of this association remains unclear.
      Objective: To examine whether there is a bidirectional association between depressive symptoms and cognitive function in English adults aged 50 years or older throughout a 16-year follow-up period.
      Design, Setting, and Participants: This cohort study included a nationally representative sample of community-dwelling English adults aged 50 years or older. The current analysis included 8268 eligible participants with relevant data. These participants were examined every other year from 2002 and 2003 until 2018 and 2019, resulting in a follow-up period of up to 16 years. Data were analyzed from July to November 2023.
      Main Outcomes and Measures: The bivariate dual change score models were used to estimate the multivariable associations between depressive symptoms and cognitive function, which were interchangeably used as exposures and outcomes. Cognitive measures include memory and verbal fluency tests, while the Center for Epidemiologic Studies Depression Scale evaluated depressive symptoms.
      Results: The study population of 8268 participants had a mean (SD) age of 64 (10) years at the study baseline, and 4517 participants (55%) were female. Higher depressive symptoms were cross-sectionally associated with poorer memory (β intercept, -0.018; standard error [SE], 0.004; P < .001) and verbal fluency (β intercept, -0.009; SE, 0.004; P = .02) at study baseline. A steeper linear change in depressive symptoms was associated with an accelerated memory change (β intercept, -0.253; SE, 0.079; P = .001), and a linear change in memory was associated with an acceleration in depressive symptoms over time (β intercept, 0.016; SE, 0.006; P = .005). This bidirectional change was not observed with verbal fluency.
      Conclusions and Relevance: In this study, greater depressive symptoms were associated with poorer memory at the study baseline and steeper memory change over time. A gradual linear change in depressive symptoms contributed to accelerated memory loss and vice versa, suggesting that psychological mood and memory performance are intrinsically associated.
    • References:
      Nat Rev Neurol. 2011 May 03;7(6):323-31. (PMID: 21537355)
      J Gerontol A Biol Sci Med Sci. 2005 Jun;60(6):744-7. (PMID: 15983177)
      Annu Rev Psychol. 2012;63:201-26. (PMID: 21740223)
      J Affect Disord. 2023 Jan 1;320:621-627. (PMID: 36206885)
      Int J Epidemiol. 2019 Dec 1;48(6):1937-1948. (PMID: 31056641)
      Arch Neurol. 1991 Sep;48(9):949-55. (PMID: 1953420)
      Intelligence. 2015 Nov-Dec;53:23-32. (PMID: 26766880)
      J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):126-9. (PMID: 14707321)
      J Affect Disord. 2023 Oct 1;338:449-458. (PMID: 37356735)
      Semin Hear. 2015 Aug;36(3):111-21. (PMID: 27516712)
      Neurology. 2004 Nov 23;63(10):1960-1. (PMID: 15557525)
      JAMA. 2018 Sep 11;320(10):961-962. (PMID: 30140930)
      Cochrane Database Syst Rev. 2014 Apr 10;(4):CD010079. (PMID: 24719028)
      JAMA Psychiatry. 2018 Jul 1;75(7):723-732. (PMID: 29799983)
      Cortex. 1993 Jun;29(2):293-304. (PMID: 8348826)
      J Affect Disord. 2021 Nov 1;294:357-365. (PMID: 34315097)
      Neurology. 2002 Aug 13;59(3):364-70. (PMID: 12177369)
      Int J Epidemiol. 2013 Dec;42(6):1640-8. (PMID: 23143611)
      Neurology. 2018 Jan 16;90(3):126-135. (PMID: 29282327)
      Br J Clin Psychol. 1984 Feb;23 ( Pt 1):53-7. (PMID: 6697028)
      Psychol Med. 2012 Oct;42(10):2057-69. (PMID: 23206378)
      Psychol Med. 1994 Feb;24(1):145-53. (PMID: 8208879)
      Ageing Res Rev. 2022 Apr;76:101577. (PMID: 35104629)
      Lancet Psychiatry. 2021 Jan;8(1):48-57. (PMID: 33181096)
      Chronic Stress (Thousand Oaks). 2017 Jan-Dec;1:. (PMID: 28856337)
      BMJ. 2011 Sep 28;343:d5219. (PMID: 21957206)
      Trends Cogn Sci. 2009 Oct;13(10):447-54. (PMID: 19726219)
      Endocr Rev. 1991 May;12(2):118-34. (PMID: 2070776)
      Eur Heart J. 2022 Feb 12;43(7):e2-e9. (PMID: 29020327)
      J Pers Assess. 1996 Feb;66(1):20-40. (PMID: 8576833)
      Aust N Z J Psychiatry. 2001 Dec;35(6):768-75. (PMID: 11990887)
      Eur Geriatr Med. 2018 Feb;9(1):121-126. (PMID: 34654281)
      Front Psychol. 2014 Jul 22;5:772. (PMID: 25101034)
      J Affect Disord. 2022 Apr 15;303:18-23. (PMID: 35108603)
      Psychoneuroendocrinology. 2014 Mar;41:46-62. (PMID: 24495607)
      Arch Neurol. 1989 Feb;46(2):141-5. (PMID: 2916953)
      Dev Psychopathol. 2017 Nov 16;:1-15. (PMID: 29144220)
      Physiol Rev. 2007 Jul;87(3):873-904. (PMID: 17615391)
      Neurology. 1994 Apr;44(4):609-14. (PMID: 8164812)
    • Publication Date:
      Date Created: 20240611 Date Completed: 20240611 Latest Revision: 20240614
    • Publication Date:
      20240614
    • Accession Number:
      PMC11167501
    • Accession Number:
      10.1001/jamanetworkopen.2024.16305
    • Accession Number:
      38861255